The Effect of Sucrose on Pain Relief During Venous Blood Sampling in Preterm Infants
1 other identifier
interventional
50
2 countries
2
Brief Summary
Despite the fact that oral sucrose is the most frequently studied non-pharmacological intervention for procedural pain relief in infants, there is a paucity of data on the minimal effective dose. The aim of this study is to find the minimal effective dose of sucrose to reduce pain during a single venous blood sampling procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Jan 2015
Typical duration for not_applicable pain
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 16, 2015
CompletedFirst Posted
Study publicly available on registry
January 26, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedJune 4, 2020
July 1, 2016
1.4 years
January 16, 2015
June 2, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
pain
assessed by Premature Infant Pain Profile-Revised (PIPP-R). Pain score related to the blood sampling will be performed two times: at skin puncture and immediately after the needle has been removed
1 week
Study Arms (2)
0.2 ml sucrose
EXPERIMENTALon 2 occasions within 1 week 0.2 ml sucrose 25% or 0.5 ml sucrose 25% will be given in randomized order to the same infant during blood sampling
0.5 ml sucrose
EXPERIMENTALon 2 occasions within 1 week 0.2 ml sucrose 25% or 0.5 ml sucrose 25% will be given in randomized order to the same infant during blood sampling
Interventions
Administered on the tongue by a syringe, a half dose two minutes before blood sampling and the other half dose immediately before sampling
Administered on the tongue by a syringe, a half dose two minutes before blood sampling and the other half dose immediately before sampling
Eligibility Criteria
You may qualify if:
- born preterm
- more than 1000 gram
You may not qualify if:
- severe intraventricular hemorrhage
- cerebral malformations
- other malformations requiring surgery
- medication that may impair pain expression (opioids, paracetamol, sedatives)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
- Lower Umfolozi Regional War Memorial Hospitalcollaborator
Study Sites (2)
St Olavs Hospital
Trondheim, Norway
Lower Umfolozi Rigional War Memorial Hospital, NICU
Empangeni, South Africa
Related Publications (1)
Kristoffersen L, Malahleha M, Duze Z, Tegnander E, Kapongo N, Stoen R, Follestad T, Eik-Nes SH, Bergseng H. Randomised controlled trial showed that neonates received better pain relief from a higher dose of sucrose during venepuncture. Acta Paediatr. 2018 Dec;107(12):2071-2078. doi: 10.1111/apa.14567. Epub 2018 Oct 2.
PMID: 30188590RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Håkon Bergseng, MD PhD
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2015
First Posted
January 26, 2015
Study Start
January 1, 2015
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
June 4, 2020
Record last verified: 2016-07